Evidence map›Paper›PMID 38947924›Full record

ArticleArXiv2024

ULV: A robust statistical method for clustered data, with applications to multi-subject, single-cell omics data.

Mingyu Du, Kevin Johnston, Veronica Berrocal, Wei Li, Xiangmin Xu, Zhaoxia Yu

Abstract readPreprint
In one paragraph

Article in ArXiv, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mingyu DuCenter for Complex Biological Systems, University of California, Irvine, 92697, CA, USA.
Kevin JohnstonDepartment of Anatomy and Neurobiology, University of California, Irvine, 92697, CA, USA.
Veronica BerrocalDepartment of Statistics, University of California, Irvine, 92697, CA, USA.
Wei LiDivision of Computational Biomedicine, Department of Biological Chemistry, School of Medicine, University of California, Irvine, 92697, CA, USA.
Xiangmin XuDepartment of Anatomy and Neurobiology, University of California, Irvine, 92697, CA, USA.
Zhaoxia YuDepartment of Statistics, University of California, Irvine, 92697, CA, USA.

Funding

Cell-type-specific neural circuit connectomes in the mouse models of aging and Alzheimer's diseaseU01AG076791 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI Kim Green, ERAN A MUKAMEL · 2022 to 2026
$13.6M
Single-cell transcriptomic and epigenomic analysis of brain cell vulnerabilities to tauopathies in early AD impacted brain regionsR01AG082127 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI MICHAEL D KOOB, Bing Ren · 2023 to 2026
$8.1M
Epigenomic analysis of neural circuits in Alzheimer's disease mouse modelsR01AG067153 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI REN, BING, XU, XIANGMIN · 2020 to 2024
$3.8M
NIDCD T32 Interdisciplinary Training Program in Hearing ResearchT32DC010775 · NIDCD · UNIVERSITY OF CALIFORNIA-IRVINE · PI Karina S Cramer, Raju Metherate · 2010 to 2026
$3.5M
Single-Cell Analysis of Aging-Associated 4D Nucleome in the Human HippocampusU01DA052769 · NIDA · UNIVERSITY OF CALIFORNIA-IRVINE · PI REN, BING, XU, XIANGMIN · 2020 to 2024
$3.4M
Neural circuit mechanisms underlying AD-related memory impairmentsRF1AG065675 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI XU, XIANGMIN · 2020 to 2020
$1.9M
NIA NIH HHS R01 AG067153NIA NIH HHS R01 AG082127NIA NIH HHS RF1 AG065675NIA NIH HHS U01 AG076791NIDA NIH HHS U01 DA052769NIDCD NIH HHS T32 DC010775
6 · The paper itself

Abstract

Molecular and genomic technological advancements have greatly enhanced our understanding of biological processes by allowing us to quantify key biological variables such as gene expression, protein levels, and microbiome compositions. These breakthroughs have enabled us to achieve increasingly higher levels of resolution in our measurements, exemplified by our ability to comprehensively profile biological information at the single-cell level. However, the analysis of such data faces several critical challenges: limited number of individuals, non-normality, potential dropouts, outliers, and repeated measurements from the same individual. In this article, we propose a novel method, which we call U-statistic based latent variable (ULV). Our proposed method takes advantage of the robustness of rank-based statistics and exploits the statistical efficiency of parametric methods for small sample sizes. It is a computationally feasible framework that addresses all the issues mentioned above simultaneously. We show that our method controls false positives at desired significance levels. An additional advantage of ULV is its flexibility in modeling various types of single-cell data, including both RNA and protein abundance. The usefulness of our method is demonstrated in two studies: a single-cell proteomics study of acute myelogenous leukemia (AML) and a single-cell RNA study of COVID-19 symptoms. In the AML study, ULV successfully identified differentially expressed proteins that would have been missed by the pseudobulk version of the Wilcoxon rank-sum test. In the COVID-19 study, ULV identified genes associated with covariates such as age and gender, and genes that would be missed without adjusting for covariates. The differentially expressed genes identified by our method are less biased toward genes with high expression levels. Furthermore, ULV identified additional gene pathways likely contributing to the mechanisms of COVID-19 severity.

Identifiers

PMID38947924
PMCPMC11213121

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.